Default Category
-
Sea Breeze Capital (B)
Menden, Lenka; Liechtenstein, Heinrich; Kelly, Peter; Johnson, RobCase F-889Entrepreneurship, FinanceEn la primavera de 2012, Jordi Alves estaba enfrentando algunas decisiones difíciles. Un año antes, tras un proceso que había durado más de lo esperado, había logrado recaudar el primer fondo de búsqueda en España. Así, había dedicado un año entero a buscar una empresa para adquirirla y ahora tenía lo que parecían dos buenas adquisiciones sobre la mesa. La cuestión ahora era qué hacer. ¿Qué adquisición debía emprender? ¿Debía hacerlo? Además, no ...Starting at €5.74
-
Schneider Drinks (B). Solicitud de préstamo adicional
Stodieck J.; Liechtenstein, HeinrichCase F-774FinanceStarting at €5.74
-
Starbucks, Howard Schultz, and the Trump Effect
W. Glenn Rowe; Ken MarkCase IVEY-9B19M117-EStrategyAfter the former chief executive officer (CEO) of U.S.-based Starbucks started to voice his political opinions in September 2016, both Starbucks and the CEO faced backlash. As the CEO and former chairman of a large company, he may have felt entitled to voStarting at €8.20
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing - Teaching Note
Liechtenstein, Heinrich; Kolarova, LenkaTeaching Note ET-34-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €0.00
-
Canopy Growth Corporation: Accounting Problems in the Cannabis Industry?
Mary Gillett; Morgan HartCase IVEY-9B21B007-EAccounting and ControlIn November 2019, John Fowler, founder and principle of consulting firm Blaise Ventures (Blaise) had been listening to a conference call where the management of Canopy Growth Corporation (Canopy) had reported its financial results for its second quarter ended September 30, 2019. Cannabis companies faced a wide array of complex financial reporting issues, and Fowler felt that being able to understand these issues and explain them to clients was cr...Starting at €8.20
-
To Brew or Not to Brew: The Corkford Brewery Acquisition
Mary Gillett; Chris Sturby; Brittney MacKinnonCase IVEY-9B19B007-EAccounting and Control, EntrepreneurshipIn 2017, the president and co-owner of MacKinnon Industries was considering the opportunity to diversify his business and bring a former family business back into the MacKinnon family. With an extensive background in acquiring and managing manufacturing bStarting at €8.20
-
Valeant Pharmaceuticals: Eroded Reputation and Stock Price
Mary Gillett; Amy HorrocksCase IVEY-9B20B014-EAccounting and ControlIn early January 2019, a recent Ivey Business School graduate logged into her online trading account to review her portfolio’s performance. As she scanned her investments, she paused at one stock in particular. It was time to make a decision regarding one of her most volatile stocks—Valeant Pharmaceuticals International Inc., recently renamed Bausch Health Companies Inc. The pharmaceutical company was once celebrated for its innovative business a...Starting at €8.20
-
Maxim Off Highway Axle Business: An Acquisition Opportunity (B)
Mary Gillett; Mark A. HeiszCase IVEY-9B12B033-EAccounting and Control, FinanceThis case is a supplement to Maxim Off Highway Axle Business: An Acquisition Opportunity (A).Starting at €5.74
-
Taurion Inc. - Built to Cure an Incurable Disease (Entrepreneurs)
Ramírez Maz, Daniel; Liechtenstein, Heinrich; Grabenwarter, UliCase F-873-EEntrepreneurship, Finance, Innovation and ChangeTaurion Inc. is a start-up company established in 2006 and based in Vienna. It specializes in researching the causes of Alzheimer's disease (AD) as well as developing diagnostic tools and targeted drugs to combat it. For several years, the founders of the company - two renowned scientists and a finance professional - have been focusing on the role of one deficient protein present in the brains of Alzheimer's patients, the tau protein, which is be...Starting at €8.20
-
ExQuisit IV European Private Equity Fund: To Invest or Not
Grabenwarter, Uli; Liechtenstein, HeinrichCase F-826-EFinanceThis case introduces an in-class analysis of a private placement memorandum (PPM) of a new private equity fund. Students will evaluate the PPM along the following criteria: the fund's investment strategy, past financial performance, expected returns, the size of the fund's targets, the regions and sectors, holding periods, governance issues, the fund's team and benchmark data.Starting at €8.20